体细胞突变
酵母
抗体
生物
遗传学
计算生物学
化学
细胞生物学
B细胞
作者
Alon Wellner,Conor McMahon,Morgan S. A. Gilman,Jonathan R. Clements,Sarah A. Clark,Kianna M. Nguyen,Ming Hua Ho,Vincent J. Hu,Jung-Eun Shin,Jared Feldman,Blake M. Hauser,Timothy M. Caradonna,Laura M. Wingler,Aaron G. Schmidt,Debora S. Marks,Jonathan Abraham,Andrew C. Kruse,Chang C. Liu
标识
DOI:10.1038/s41589-021-00832-4
摘要
The predominant approach for antibody generation remains animal immunization, which can yield exceptionally selective and potent antibody clones owing to the powerful evolutionary process of somatic hypermutation. However, animal immunization is inherently slow, not always accessible and poorly compatible with many antigens. Here, we describe 'autonomous hypermutation yeast surface display' (AHEAD), a synthetic recombinant antibody generation technology that imitates somatic hypermutation inside engineered yeast. By encoding antibody fragments on an error-prone orthogonal DNA replication system, surface-displayed antibody repertoires continuously mutate through simple cycles of yeast culturing and enrichment for antigen binding to produce high-affinity clones in as little as two weeks. We applied AHEAD to generate potent nanobodies against the SARS-CoV-2 S glycoprotein, a G-protein-coupled receptor and other targets, offering a template for streamlined antibody generation at large.
科研通智能强力驱动
Strongly Powered by AbleSci AI